Enhancing the Stability of <sup>211</sup>At Radiopharmaceuticals: Insights from Ortho-Substituent Strategies. [PDF]
Zhao T, Liang SH.
europepmc +1 more source
Tailored Reaction Conditions and Automated Radiolabeling of [<sup>177</sup>Lu]Lu-PSMA-ALB-56 in a <sup>68</sup>Ga Setting: The Critical Impact of Antioxidant Concentrations. [PDF]
Vanney J +3 more
europepmc +1 more source
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer? [PDF]
García Megías I +6 more
europepmc +1 more source
Facilitating PET Imaging: Eco-Friendly Purification Using Solid-Phase Material for Labeling Metal-Based Radiopharmaceuticals. [PDF]
Yeung YH +8 more
europepmc +1 more source
Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use
S.C. Srivastava, George E Meinken
openalex +1 more source
Radiopharmaceuticals and their applications in medicine
Radiopharmaceuticals involve the local delivery of radionuclides to targeted lesions for the diagnosis and treatment of multiple diseases. Radiopharmaceutical therapy, which directly causes systematic and irreparable damage to targeted cells, has ...
Siqi Zhang +9 more
semanticscholar +4 more sources
Related searches:
Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals
Nuclear Medicine Communications, 2021Radiopharmaceuticals are radioactive compounds used in nuclear medicine, consisting of a radioactive moiety and a pharmaceutical part. Radiopharmaceuticals are used for diagnosis (predominantly) and therapy (to a lesser extent). Adverse drug reactions are undesirable, unexpected, often harmful drug responses that occur when the drug is administered in ...
Humeyra Battal, Asuman Yekta Ozer
openaire +2 more sources

